Skip to content

Donor leg morbidity and function after a fibula free flap; a comparison between the osteocutaneous and osteomyocutaneous flap

Donor leg morbidity and function after a fibula free flap; a comparison between the osteocutaneous and osteomyocutaneous flap - Donorsite morbidity and function after a free fibula flap

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34338
Enrollment
40
Registered
2010-09-29
Start date
2010-10-04
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Donorsite Morbidity after a free fibula flap

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who underwent a reconstruction with a free osteocutaneous or a free osteomyocutaneous fibula flap between 1 january 1995 and 1 november 2009

Exclusion criteria

Exclusion criteria: A history of previous surgery or trauma of the contralateral leg.

Design outcomes

Primary

MeasureTime frame
The primary study parameter is the AOFAS Ankle- Hindfoot Scale and Hallux Metatarsophalangeal- Interphalangeal Scale

Secondary

MeasureTime frame
Secondary study parameters are: - Flexion- and extension force of the hallux - Range of motion ankle and MTP-I joint - Walking distance (6 minutes) - Stability test - Sensibility - Morbidity score (subjective) - POSAS score - Ankle lining - Karlsson score (instability ankle)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)